• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康保险市场中的风险调整:勿忽视“真正”的健康人群。

Risk Adjustment in Health Insurance Markets: Do Not Overlook the "Real" Healthy.

作者信息

van Kleef Richard C, van Vliet René C J A, Oskam Michel

机构信息

Erasmus School of Health Policy & Management, and The Erasmus Centre for Health Economics Rotterdam, Erasmus University, Rotterdam, The Netherlands.

出版信息

Med Care. 2024 Nov 1;62(11):767-772. doi: 10.1097/MLR.0000000000001955. Epub 2023 Dec 4.

DOI:10.1097/MLR.0000000000001955
PMID:38047754
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11462869/
Abstract

OBJECTIVES

The goals of this paper are: (1) to identify groups of healthy people; and (2) to quantify the extent to which the Dutch risk adjustment (RA) model overpays insurers for these groups.

BACKGROUND

There have been strong signals that insurers in the Dutch regulated health insurance market engage in actions to attract healthy people. A potential explanation for this behavior is that the Dutch RA model overpays insurers for healthy people.

METHODS

We identify healthy groups using 3 types of ex-ante information (ie, information available before the start of the health insurance contract): administrative data on prior spending for specific health care services (N = 17 m), diagnoses from electronic patient records (N = 1.3 m), and health survey data (N = 457 k). In a second step, we calculate the under/overpayment for these groups under the Dutch RA model (version: 2021).

RESULTS

We distinguish eight groups of healthy people using various "identifiers." Although the Dutch RA model substantially reduces the predictable profits that insurers face for these groups, significant profits remain. The mean per person overpayment ranges from 38 euros (people with hospital spending below the third quartile in each of 3 prior years) to 167 euros (those without any medical condition according to their electronic patient record).

CONCLUSIONS

The Dutch RA model does not eliminate the profitability of healthy groups. The identifiers used for flagging these groups, however, seem inappropriate for serving as risk adjuster variables. An alternative way of exploiting these identifiers and eliminating the profitability of healthy groups is to estimate RA models with "constrained regression."

摘要

目标

本文的目标是:(1)识别健康人群组;(2)量化荷兰风险调整(RA)模型针对这些人群组向保险公司多支付的程度。

背景

有强烈迹象表明,荷兰受监管的健康保险市场中的保险公司采取行动吸引健康人群。对此行为的一种潜在解释是,荷兰RA模型针对健康人群向保险公司多支付了费用。

方法

我们使用3种事前信息(即健康保险合同开始前可得的信息)来识别健康人群组:特定医疗服务既往支出的行政数据(N = 1700万)、电子病历诊断信息(N = 130万)以及健康调查数据(N = 45.7万)。第二步,我们计算这些人群组在荷兰RA模型(版本:2021)下的少付/多付金额。

结果

我们使用各种“标识符”区分出八组健康人群。尽管荷兰RA模型大幅降低了保险公司针对这些人群组面临的可预测利润,但仍有可观利润留存。人均多付金额从38欧元(在之前3年中每年医院支出低于第三四分位数的人群)到167欧元(根据其电子病历无任何疾病的人群)不等。

结论

荷兰RA模型并未消除健康人群组的盈利性。然而,用于标记这些人群组的标识符似乎不适宜用作风险调整变量。利用这些标识符并消除健康人群组盈利性的另一种方法是采用“约束回归”估计RA模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d623/11462869/939f9798a385/mlr-62-767-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d623/11462869/0fad844bd454/mlr-62-767-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d623/11462869/939f9798a385/mlr-62-767-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d623/11462869/0fad844bd454/mlr-62-767-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d623/11462869/939f9798a385/mlr-62-767-g002.jpg

相似文献

1
Risk Adjustment in Health Insurance Markets: Do Not Overlook the "Real" Healthy.健康保险市场中的风险调整:勿忽视“真正”的健康人群。
Med Care. 2024 Nov 1;62(11):767-772. doi: 10.1097/MLR.0000000000001955. Epub 2023 Dec 4.
2
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
3
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理:一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.
4
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
5
Interventions to reduce harm from continued tobacco use.减少持续吸烟危害的干预措施。
Cochrane Database Syst Rev. 2016 Oct 13;10(10):CD005231. doi: 10.1002/14651858.CD005231.pub3.
6
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
7
Short-Term Memory Impairment短期记忆障碍
8
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
9
Automated devices for identifying peripheral arterial disease in people with leg ulceration: an evidence synthesis and cost-effectiveness analysis.用于识别下肢溃疡患者外周动脉疾病的自动化设备:证据综合和成本效益分析。
Health Technol Assess. 2024 Aug;28(37):1-158. doi: 10.3310/TWCG3912.
10
Electronic cigarettes for smoking cessation and reduction.用于戒烟和减少吸烟量的电子烟。
Cochrane Database Syst Rev. 2014(12):CD010216. doi: 10.1002/14651858.CD010216.pub2. Epub 2014 Dec 17.

引用本文的文献

1
A critical review of the use of R in risk equalization research.对R在风险均等化研究中的应用的批判性综述。
Eur J Health Econ. 2025 Apr;26(3):363-375. doi: 10.1007/s10198-024-01709-8. Epub 2024 Aug 9.

本文引用的文献

1
Do health insurers use target marketing as a tool for risk selection? Evidence from the Netherlands.健康保险公司是否将目标营销作为风险选择的工具?来自荷兰的证据。
Health Policy. 2022 Feb;126(2):122-128. doi: 10.1016/j.healthpol.2021.12.005. Epub 2021 Dec 24.
2
Improving the Performance of Risk Adjustment Systems: Constrained Regressions, Reinsurance, and Variable Selection.提升风险调整系统的性能:约束回归、再保险与变量选择
Am J Health Econ. 2021 Fall;7(4):497-521. doi: 10.1086/716199. Epub 2021 Oct 4.
3
Screening in Contract Design: Evidence from the ACA Health Insurance Exchanges.
合同设计中的筛选:来自《平价医疗法案》医疗保险交易所的证据。
Am Econ J Econ Policy. 2019 May;11(2):64-107. doi: 10.1257/pol.20170014.
4
Upcoding: Evidence from Medicare on Squishy Risk Adjustment.高编计费:来自医疗保险关于模糊风险调整的证据。
J Polit Econ. 2020 Mar;12(3):984-1026. doi: 10.1086/704756. Epub 2020 Jan 29.
5
Incorporating self-reported health measures in risk equalization through constrained regression.通过约束回归将自我报告的健康措施纳入风险均等化。
Eur J Health Econ. 2020 Jun;21(4):513-528. doi: 10.1007/s10198-019-01146-y. Epub 2020 Jan 8.
6
Estimating Morbidity Rates Based on Routine Electronic Health Records in Primary Care: Observational Study.基于基层医疗中常规电子健康记录估算发病率:观察性研究。
JMIR Med Inform. 2019 Jul 26;7(3):e11929. doi: 10.2196/11929.
7
Strategic Formulary Design in Medicare Part D Plans.医疗保险D部分计划中的战略处方集设计。
Am Econ J Econ Policy. 2018 Aug;10(3):154-192. doi: 10.1257/pol.20160248.
8
Risk equalization in competitive health insurance markets: Identifying healthy individuals on the basis of multiple-year low spending.竞争性健康保险市场中的风险均衡:基于多年低支出识别健康个体。
Health Serv Res. 2019 Apr;54(2):455-465. doi: 10.1111/1475-6773.13065. Epub 2018 Oct 16.
9
Plan responses to diagnosis-based payment: Evidence from Germany's morbidity-based risk adjustment.基于诊断的支付方案应对策略:来自德国基于发病率风险调整的证据。
J Health Econ. 2017 Dec;56:397-413. doi: 10.1016/j.jhealeco.2017.03.001.
10
Insurers' response to selection risk: Evidence from Medicare enrollment reforms.保险公司对选择风险的反应:来自医疗保险登记改革的证据。
J Health Econ. 2017 Dec;56:383-396. doi: 10.1016/j.jhealeco.2017.02.007.